European Medicines Agency

Global markets face volatility amid inflation and rate fears

32 clusters · 375 sources · last updated about 23 hours ago

Latest: Wall Street declines as oil prices reach four-year high

By mid-October 2026, global markets continued to react to shifting geopolitical tensions and economic indicators. Following a period of volatility driven by Federal Reserve interest rate hikes, U.S. equities saw a reboun

Bulgarian medicinal product shortages

3 clusters · 6 sources · last updated 1 day ago

Latest: Bulgaria debates medicine shortages amid EU supply chain discussions

Bulgaria is facing significant challenges regarding the availability of essential medications. The Bulgarian Association for Patient Protection (BAP) has raised concerns over proposed changes to the Specialized Electroni

GLP-1 drugs: clinical trends, safety, and market shifts

314 clusters · 1157 sources · last updated 1 day ago

Latest: GLP-1 medications and weight management strategies

The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, and neurodegenerative health. Cardiovascular benefits rema

Novo Nordisk pivots strategy to counter patent cliff

112 clusters · 548 sources · last updated 1 day ago

Latest: Novo Nordisk faces intense competition in obesity drug market

Novo Nordisk is implementing a strategic reset to address long-term growth concerns and the looming patent expiration of semaglutide in the early 2030s. To diversify its portfolio and counter competition from Eli Lilly,

Alzheimer's research: Detection, trials, and efficacy debate

24 clusters · 91 sources · last updated 2 days ago

Latest: Researchers identify new therapeutic pathways for Alzheimer's disease

Research into Alzheimer’s disease continues to evolve, focusing on early detection, molecular mapping, and the physiological breadth of the condition. While previous efforts emphasized biomarkers and AI-driven diagnostic

Lifestyle impacts on digestive and nutritional health

4 clusters · 16 sources · last updated 2 days ago

Latest: Dietary habits and their impact on blood sugar and digestion

Discussions regarding digestive wellness have focused on the relationship between dietary habits, sleep, and physiological responses. Research indicates that cooked legumes can reduce glycemic response, even in adults wi

Clinical applications and access of CAR-T and myeloma cell/m

20 clusters · 71 sources · last updated 2 days ago

Latest: Medical advancements in immunotherapy and autoimmune treatments

CAR-T cell therapy continues to expand its clinical utility across oncology and autoimmune diseases. In oncology, the therapy is transforming treatment for aggressive lymphomas and resistant blood cancers. A significant

Italy influenza, COVID-19 and RSV vaccination rollout

21 clusters · 200 sources · last updated 3 days ago

Latest: Italy launches 2026-2027 influenza vaccination campaign

The 2026-2027 seasonal vaccination campaign in Italy, targeting influenza, COVID-19, and Respiratory Syncytial Virus (RSV), is underway following preparations in September. Ahead of the October rollout, the Italian Medic

AIFA pharmaceutical innovation and evaluation discussions

2 clusters · 10 sources · last updated 3 days ago

Latest: AIFA President Nisticò discusses pharmaceutical innovation and drug authorization

The Italian Medicines Agency (AIFA) has initiated institutional dialogues focused on the value of pharmaceutical innovation and its impact on the Italian National Health Service. During a conference in Genoa, discussions

Expanding therapeutic uses and regulatory approvals for GLP-

33 clusters · 154 sources · last updated 3 days ago

Latest: GLP-1 medications show weight loss challenges regarding muscle mass and maintenance

Medical research continues to expand the therapeutic potential of GLP-1 receptor agonists like semaglutide and tirzepatide. While semaglutide is widely used for weight loss and diabetes, new evidence suggests it may slow

Adrenaline nasal spray developments for anaphylaxis

2 clusters · 16 sources · last updated 4 days ago

Latest: Italy approves adrenaline nasal spray for anaphylaxis treatment

Developments regarding adrenaline nasal sprays as an alternative to traditional auto-injectors for treating anaphylaxis have emerged in Europe. In Italy, the Italian Medicines Agency (AIFA) has approved the spray for us

Keytruda therapeutic expansions and approvals

2 clusters · 24 sources · last updated 4 days ago

Latest: European Commission approves bladder cancer treatment

The immunotherapy drug Keytruda has seen recent developments regarding new formulations and expanded clinical applications. In South Korea, MSD Korea announced the October launch of a subcutaneous (SC) formulation of Ke

EMA CHMP and EU Commission medicinal product approvals

3 clusters · 24 sources · last updated 4 days ago

Latest: European Commission approves Ocrevus for pediatric multiple sclerosis

In September 2026, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended the approval of 12 new medicines and therapeutic extensions for 11 existing ones. Among the

Bulgaria faces flu vaccine shortages and legislative shifts

13 clusters · 34 sources · last updated 5 days ago

Latest: Bulgaria receives first 150,000 seasonal flu vaccine doses

Bulgaria has entered the influenza season following the isolation of the A(H3N2) virus in Sofia. Experts, including Assoc. Prof. Trifon Valkov, have identified three primary strains expected to circulate: two Type A vari

FDA approves Rasonque; EMA recommends for pancreatic cancer

44 clusters · 321 sources · last updated 6 days ago

Latest: Pancreatic cancer: New research and treatment developments in Greece

On 26 August 2026, the U.S. Food and Drug Administration (FDA) granted expedited approval to daraxonrasib, marketed as Rasonque, for treating adults with metastatic pancreatic ductal adenocarcinoma (PDAC). Developed by R

EMA recommendation for Eli Lilly obesity medication

2 clusters · 15 sources · last updated 8 days ago

Latest: Eli Lilly's Foundayo receives positive EMA recommendation for obesity and diabetes

The European Medicines Agency (EMA) has issued a positive recommendation via its Committee for Medicinal Products for Human Use (CHMP) for Eli Lilly’s oral medication, Foundayo (orforglipron). The drug is a small-molecul

Daraxonrasib development for pancreatic cancer

2 clusters · 5 sources · last updated 8 days ago

Latest: EMA recommends Daraxonrasib for advanced pancreatic cancer treatment

In September 2026, Felice Antonio Spaccavento, a health official in the Puglia region of Italy, formally requested that the Italian Medicines Agency (AIFA) accelerate access to the targeted therapy daraxonrasib. The requ

Evolution of obesity medication treatments

3 clusters · 9 sources · last updated 9 days ago

Latest: Obesity research advances toward oral treatments

The landscape of obesity treatments is shifting toward more convenient delivery methods, specifically weekly injections and oral therapies. In the United States, Viking Therapeutics is preparing to begin phase 3 clinical

Achondroplasia clinical trial and regulatory developments

3 clusters · 8 sources · last updated 10 days ago

Latest: Ascendis Pharma receives positive EU opinion for achondroplasia drug

Clinical developments for achondroplasia treatments have shown positive results across different therapeutic approaches. Abbisko Therapeutics reported preliminary Phase II data for lavengratinib (ABSK061), an oral FGFR

Thyroid eye disease drug funding dispute in Spain

2 clusters · 7 sources · last updated 10 days ago

Latest: Roche receives FDA approval for Enspryng to treat thyroid eye disease

In Spain, the Spanish Association of Patients with Thyroid Eye Disease (EOT España) is demanding that the Ministry of Health and autonomous communities rectify a decision to deny funding for teprotumumab. The association

Global hormone replacement therapy shortages

8 clusters · 29 sources · last updated 11 days ago

Latest: Spain faces shortages of menopause hormone replacement therapies

The shortage of hormone replacement therapy (HRT) medications, specifically estrogen and progesterone, continues to create significant healthcare access challenges. In the United States, the scarcity of estrogen patches

AI-driven drug discovery and regulatory integration

19 clusters · 57 sources · last updated 11 days ago

Latest: AI and robotics enter pharmaceutical quality control laboratories

By late 2026, the pharmaceutical industry has transitioned from pilot programs to full-scale execution, focusing on a ‘data closed loop’ through major partnerships such as Eli Lilly and NVIDIA, and Merck & Co., Inc. with

Pharmaceutical impurity recalls in Poland

2 clusters · 5 sources · last updated 12 days ago

Latest: Polish regulators reject Polpharma application and withdraw Dutilox from market

Polish pharmaceutical regulators have initiated several actions involving the recall and withdrawal of medications due to the presence of nitrosamine impurities, which are potentially carcinogenic. Initially, the Chief

EMA women's health research initiative

3 clusters · 8 sources · last updated 12 days ago

Latest: European health agencies move to prioritize women in medical research

The European Medicines Agency (EMA) is developing a regulatory roadmap to address critical gaps in medical research and drug development for women’s health. Following an expert workshop in Amsterdam in late September 202

EMA cancer therapy approval recommendations

2 clusters · 4 sources · last updated 14 days ago

Latest: EMA recommends approval for three new lung and ovarian cancer therapies

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued positive recommendations for several new cancer therapies. Initially, the CHMP recommended the approval of Lifyorli (relac

Biopharmaceutical manufacturing expansion in Songdo

3 clusters · 7 sources · last updated 15 days ago

Latest: South Korean biotech firms expand global presence and Japanese market reach

Biopharmaceutical manufacturing capacity is expanding within the Songdo Bio Cluster in South Korea. Celltrion has renewed its European Medicines Agency (EMA) Good Manufacturing Practice (EU-GMP) certification for its d

Poland COVID-19 and seasonal vaccination guidelines 2026/27

9 clusters · 33 sources · last updated 18 days ago

Latest: Poland faces early respiratory infection season and healthcare access challenges

The Polish Ministry of Health has initiated the 2026/2027 COVID-19 vaccination campaign, with supply distribution for individuals aged 12 and older beginning on September 11. Pediatric versions of the Spikevax XFG vaccin

Northern Europe influenza vaccine supply delays

2 clusters · 8 sources · last updated 19 days ago

Latest: Latvia begins influenza monitoring season amid vaccine delays

In late 2026, Lithuania and Latvia reported delays in the delivery of state-funded seasonal influenza vaccines. In Lithuania, officials projected that deliveries to medical institutions would be delayed until November.

Regulatory efforts to reduce animal testing in drug research

2 clusters · 5 sources · last updated 22 days ago

Latest: EMA supports reducing animal testing in drug development

The International Coalition of Medicines Regulatory Authorities (ICMRA) issued a joint statement calling for the accelerated development and implementation of alternatives to animal testing in human medicine development.

German vaccination recommendations for respiratory diseases

3 clusters · 17 sources · last updated 22 days ago

Latest: Germany updates COVID-19 vaccination guidelines for 2026/2027 season

Germany’s Standing Committee on Vaccination (Stiko) has issued updated guidance for the upcoming respiratory infection season, focusing on influenza, Covid-19, and RSV. For influenza, annual vaccination is recommended f